SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-302232
Filing Date
2011-11-08
Accepted
2011-11-08 16:29:40
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d250665d10q.htm 10-Q 572204
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d250665dex311.htm EX-31.1 10391
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d250665dex312.htm EX-31.2 10435
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d250665dex32.htm EX-32 7539
10 GRAPHIC g250665tx_pg022.jpg GRAPHIC 103287
  Complete submission text file 0001193125-11-302232.txt   1969555

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20110930.xml EX-101.INS 213186
6 XBRL TAXONOMY EXTENSION SCHEMA halo-20110930.xsd EX-101.SCH 9365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE halo-20110930_cal.xml EX-101.CAL 23747
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE halo-20110930_lab.xml EX-101.LAB 91791
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE halo-20110930_pre.xml EX-101.PRE 58980
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 111188169
SIC: 2836 Biological Products, (No Diagnostic Substances)